PPARA and metabolic dysfunction-associated steatohepatitis: These results show that 6-week CDAHFD in WT and PPAR KO mice, both result in MASH features including steatosis, ballooning, lobular inflammation and fibrosis, similar to liver histopathology in MASH patients.